Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 66.00% |
| Q2 2025 | -14.94% |
| Q1 2025 | -7.41% |
| Q4 2024 | 29.57% |
| Q3 2024 | -12.75% |
| Q2 2024 | -29.11% |
| Q1 2024 | 41.48% |
| Q4 2023 | -23.85% |
| Q3 2023 | 14.17% |
| Q2 2023 | 21.12% |
| Q1 2023 | -53.33% |
| Q4 2022 | -26.51% |
| Q3 2022 | 21.70% |
| Q2 2022 | -8.16% |
| Q1 2022 | 62.16% |
| Q4 2021 | -105.56% |
| Q3 2021 | 43.24% |
| Q2 2021 | 23.71% |
| Q1 2021 | 87.39% |
| Q4 2020 | -1458.78% |
| Q3 2020 | 18.68% |
| Q2 2020 | 31.32% |
| Q1 2020 | 43.50% |
| Q4 2019 | 13.47% |
| Q3 2019 | -25.75% |
| Q2 2019 | 23.72% |
| Q1 2019 | -12.55% |
| Q4 2018 | -14.09% |
| Q3 2018 | -2.09% |
| Q2 2018 | -63.26% |
| Q1 2018 | 38.60% |
| Q4 2017 | -5.91% |
| Q3 2017 | 20.70% |
| Q2 2017 | 43.49% |
| Q1 2017 | -25.31% |
| Q4 2016 | -182.42% |
| Q3 2016 | 26.86% |
| Q2 2016 | 9.09% |
| Q1 2016 | 8.11% |
| Q4 2015 | 28.01% |